Table 1.
Characteristics | TN | NC | PA | WI | P Valuea | FL | CA | NY | OH | P Valuea |
---|---|---|---|---|---|---|---|---|---|---|
Patients (n) | 4658 | 4903 | 14,329 | 4733 | 10,863 | 20,581 | 11,298 | 7374 | ||
No. of DSAs | 2 | 2 | 2 | 2 | 4 | 4 | 4 | 4 | ||
Blood type | ||||||||||
A | 39.6 | 38.2 | 39.3 | 42.0 | 0.83 | 36.6 | 36.4 | 35.1 | 38.4 | 0.89 |
AB | 5.6 | 5.3 | 5.5 | 6.2 | 0.94 | 5.1 | 5.6 | 6.4 | 5.6 | 0.85 |
B | 11.8 | 12.4 | 12.6 | 12.8 | 0.98 | 12.9 | 13.3 | 13.0 | 11.9 | 0.94 |
O | 43.0 | 44.1 | 42.7 | 38.9 | 0.67 | 45.4 | 44.8 | 45.5 | 44.1 | 0.99 |
Age at transplant | ||||||||||
0–17 yr | 3.7 | 4.1 | 4.1 | 2.4 | 0.45 | 3.8 | 6.5 | 5.1 | 3.6 | 0.08 |
18–39 yr | 28.8 | 28.2 | 23.2 | 22.7 | 0.08 | 23.7 | 27.2 | 25.4 | 25.6 | 0.65 |
40–64 yr | 60.2 | 59.2 | 57.6 | 63.0 | 0.66 | 57.2 | 55.3 | 57.3 | 60.8 | 0.73 |
≥65 yr | 7.4 | 8.5 | 15.0 | 12.0 | <0.001 | 15.3 | 10.9 | 12.2 | 10.0 | 0.09 |
Men | 62.2 | 59.2 | 62.1 | 60.8 | 0.84 | 61.2 | 59.7 | 60.5 | 61.8 | 0.97 |
Race | ||||||||||
Non-Hispanic White | 57.5 | 40.7 | 63.8 | 68.9 | <0.001 | 51.4 | 35.0 | 47.0 | 62.6 | <0.001 |
Non-Hispanic black | 40.5 | 55.1 | 29.1 | 19.9 | <0.001 | 30.9 | 15.2 | 32.1 | 33.5 | <0.001 |
Hispanic | 0.9 | 1.3 | 3.6 | 4.8 | 0.001 | 13.8 | 30.8 | 13.4 | 1.8 | <0.001 |
Asian | 0.8 | 1.5 | 2.7 | 4.9 | 0.001 | 2.7 | 15.6 | 5.9 | 1.6 | <0.001 |
Other | 0.3 | 1.3 | 0.8 | 1.6 | 0.20 | 1.2 | 3.3 | 1.5 | 0.5 | 0.01 |
Panel reactive antibodies | ||||||||||
0–19 | 81.1 | 83.9 | 85.6 | 83.4 | 0.86 | 89.1 | 88.3 | 86.5 | 85.6 | 0.95 |
20–79 | 12.9 | 11.6 | 9.6 | 11.4 | 0.31 | 8.7 | 8.2 | 9.8 | 11.0 | 0.54 |
80–100 | 6.0 | 4.5 | 4.8 | 5.2 | 0.80 | 2.3 | 3.4 | 3.7 | 3.4 | 0.62 |
Primary diagnosis | ||||||||||
Diabetes | 13.2 | 15.4 | 15.1 | 17.0 | 0.59 | 15.5 | 13.9 | 14.9 | 17.5 | 0.53 |
Glomerulosclerosis | 5.8 | 9.8 | 7.1 | 10.0 | 0.05 | 9.7 | 9.4 | 7.2 | 8.9 | 0.50 |
Hypertension | 23.4 | 18.2 | 16.6 | 10.9 | <0.001 | 19.3 | 12.7 | 17.1 | 13.8 | 0.01 |
Polycystic kidneys | 5.9 | 5.1 | 6.2 | 7.9 | 0.42 | 8.0 | 4.5 | 6.1 | 6.6 | 0.06 |
Graft failure | 6.1 | 5.1 | 5.0 | 7.5 | 0.24 | 3.6 | 5.1 | 5.7 | 5.5 | 0.47 |
Other | 45.5 | 46.4 | 50.1 | 46.6 | 0.56 | 43.8 | 54.4 | 49.1 | 47.6 | 0.05 |
Primary insurance | ||||||||||
Medicare | 58.2 | 58.9 | 32.5 | 51.3 | <0.001 | 56.5 | 40.9 | 42.4 | 43.8 | 0.003 |
Private | 32.5 | 34.7 | 4.8 | 6.1 | 0.33 | 38.0 | 40.1 | 40.6 | 47.5 | 0.37 |
Medicaid | 4.8 | 5.2 | 58.2 | 38.0 | <0.001 | 3.9 | 15.7 | 15.5 | 7.7 | <0.001 |
Other | 4.5 | 1.2 | 4.5 | 4.6 | 0.07 | 1.7 | 3.4 | 1.5 | 1.0 | 0.09 |
Some college | 51.6 | 52.8 | 49.9 | 55.9 | 0.50 | 56.8 | 56.1 | 54.9 | 55.1 | 0.98 |
Pre-emptive listing | 35.4 | 37.0 | 29.8 | 31.4 | 0.08 | 38.6 | 28.5 | 30.5 | 28.0 | 0.01 |
Unless otherwise noted, values are percentages. Patient characteristics of all transplant recipients who underwent transplantation within Tennessee (TN), North Carolina (NC), Pennsylvania (PA), Wisconsin (WI), Florida (FL), California (CA), New York (NY), and Ohio (OH) are listed for the study period (1987–2009). In 1991 and 1992, respectively, TN and FL implemented the Statewide Sharing variance. The P value illustrates the magnitude of difference between the states for a specific patient characteristic. DSA, donor service area.
A chi-squared test was used to calculate P values to determine significant differences across the four respective states.